241 results
Page 5 of 13
8-K
EX-99.1
tf9k bc2x
27 Oct 21
Alkermes plc Reports Third Quarter 2021 Financial Results
7:05am
8-K
EX-99.2
nq3 c6akb
27 Oct 21
Alkermes plc Reports Third Quarter 2021 Financial Results
7:05am
8-K
EX-99.2
0x44hzbk9
28 Jul 21
Alkermes plc Reports Second Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
p4vl dft3h
1 Jun 21
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
7:09am
DEFA14A
EX-99.1
jpvxx3yvny
20 May 21
Additional proxy soliciting materials
7:11am
8-K
EX-99.1
uehnuax7srwm0ll481rq
20 May 21
Alkermes Announces the Appointment of Emily Peterson Alva to its Board of Directors
7:10am
DEFA14A
EX-99.1
q2x 2v4byrtvo1xgq102
30 Apr 21
Additional proxy soliciting materials
7:11am
8-K
EX-99.1
dz2psaafd8stl
30 Apr 21
Alkermes Announces Agreement with Sarissa Capital
7:10am
8-K
EX-99.2
2763lx43b40xj5ci
28 Apr 21
Alkermes plc Reports First Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
2qpx8lz9pipdanfc28s
28 Apr 21
Alkermes plc Reports First Quarter 2021 Financial Results
7:05am
8-K
EX-99.1
34axf 41wtc6k5n85o6f
25 Mar 21
Regulation FD Disclosure
12:00am
8-K
EX-99.2
ljoq67v 11m25bbx
11 Feb 21
Results of Operations and Financial Condition
7:05am